91 – 100 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response.
(
- Contribution to journal › Article
-
Mark
Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression.
(
- Contribution to journal › Article
-
Mark
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.
(
- Contribution to journal › Article
-
Mark
A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells.
(
- Contribution to journal › Article
-
Mark
Cyclin E overexpression obstructs infiltrative behavior in breast cancer: a novel role reflected in the growth pattern of medullary breast cancers.
(
- Contribution to journal › Article
-
Mark
Microarray-based Analyses of Hypoxia-induced Transcriptional Changes in Breast Cancer Cell Lines
(
- Contribution to journal › Article
- 2004
-
Mark
Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer
(
- Contribution to journal › Article
-
Mark
Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
(
- Contribution to journal › Article
-
Mark
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.
(
- Contribution to journal › Article